LONDON — The NHS has announced a significant expansion of its respiratory syncytial virus (RSV) vaccination programme, with thousands more vulnerable adults set to become eligible for protection before the winter season.

From September, adults aged 65 to 74 who have chronic respiratory conditions or weakened immune systems will be offered the RSV vaccine through the NHS. Health officials say the move is designed to reduce serious illness, hospital admissions and pressure on healthcare services during the colder months.

RSV is a common respiratory virus that can cause severe lung infections, including pneumonia, particularly among older adults and people with underlying health conditions. By widening eligibility, the NHS aims to improve protection for those most at risk while strengthening its winter preparedness strategy.

Healthcare leaders have welcomed the expanded programme, noting that vaccination remains one of the most effective ways to prevent severe respiratory disease and ease seasonal demand on hospitals.

The rollout is expected to begin across England in September, with eligible patients encouraged to accept their invitation when contacted by their GP practice or local NHS vaccination service.